Pharma-Bio Serv (PBSV) Return on Capital Employed (2011 - 2026)

Pharma-Bio Serv's Return on Capital Employed history runs 14 years deep, the most recent figure standing at 3.46% for Q2 2026.

• Return on Capital Employed for Q2 2026 came in at 3.46%, up 204.0% year-over-year; the trailing twelve-month figure through Apr 2026 was 3.46% (up 204.0% YoY), and the FY2025 annual result was 4.82%, up 312.0% from the prior year.
• Return on Capital Employed came in at 3.46% for Q2 2026 at Pharma-Bio Serv, up from 6.22% in the prior quarter.
• In the past five years, Return on Capital Employed ranged from a high of 7.64% in Q3 2023 to a low of 20.97% in Q3 2022.
• A 5-year average of 4.29% and a median of 5.41% in 2025 frame the typical range for Return on Capital Employed.
• Across the five-year window, Return on Capital Employed plunged 2665 bps in 2022 and jumped 2861 bps in 2023, its largest moves.
• Over 5 years, Return on Capital Employed stood at 6.39% in 2022, then dropped by 3 bps to 6.23% in 2023, then tumbled by 243 bps to 8.93% in 2024, then surged by 40 bps to 5.37% in 2025, then surged by 36 bps to 3.46% in 2026.
• The last three Return on Capital Employed figures came in at 3.46% (Q2 2026), 6.22% (Q1 2026), and 5.37% (Q4 2025), per Business Quant data.